Your browser doesn't support javascript.
Risk perception and knowledge of COVID-19 in patients with celiac disease.
Zhen, Jamie; Stefanolo, Juan Pablo; Temprano, María de la Paz; Seiler, Caroline L; Caminero, Alberto; de-Madaria, Enrique; Huguet, Miguel Montoro; Santiago, Vivas; Niveloni, Sonia Isabel; Smecuol, Edgardo Gustavo; Dominguez, Luis Uzcanga; Trucco, Elena; Lopez, Virginia; Olano, Carolina; Mansueto, Pasquale; Carroccio, Antonio; Green, Peter H; Duerksen, Donald; Day, Andrew S; Tye-Din, Jason A; Bai, Julio César; Ciacci, Carolina; Verdú, Elena F; Lebwohl, Benjamin; Pinto-Sanchez, M Ines.
  • Zhen J; Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
  • Stefanolo JP; Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
  • Temprano MP; Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
  • Seiler CL; Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
  • Caminero A; Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
  • de-Madaria E; Department of Pancreatic Unit, Hospital General Universitario de Alicante, Alicante 03010, Spain.
  • Huguet MM; Department of Medicine, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza 50009, Spain.
  • Santiago V; Department of Gastroenterology, Univ Hosp Leon, Gastroenterol Unit, Altos de Nava S-N, Leon 24071, Spain.
  • Niveloni SI; Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
  • Smecuol EG; Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
  • Dominguez LU; Department of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico DF 14080, Mexico.
  • Trucco E; Department of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
  • Lopez V; Department of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
  • Olano C; Department of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
  • Mansueto P; Department of Internal Medicine, PROMISE Department, University of Palermo, Palermo 90127, Italy.
  • Carroccio A; Department of Internal Medicine, V. Cervello Hospital, PROMISE Department, University of Palermo, Palermo 90127, Italy.
  • Green PH; Celiac Disease Center, Columbia University Medical Center, Columbia Univ, Celiac Dis Ctr, Div Digest and Liver Dis, New York, NY 10032, United States.
  • Duerksen D; Department of Medicine, St Boniface Gen Hosp, University of Manitoba, Winnipeg R2H 2A6, Canada.
  • Day AS; Department of Paediatrics, University of Otago Christchurch, Christchurch 8041, New Zealand.
  • Tye-Din JA; Department of Gastroenterology, Royal Melbourne Hospital, Immunology Division, Walter and Eliza Hall Institute, Melbourne 3052, Australia.
  • Bai JC; Department of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
  • Ciacci C; Department of Medicine, Surgery and Dentry, Scuola Medica Salernitana, University of Salerno, Celiac Center at the University Hospital San Giovanni di Dio e Ruggi di Aragona, Salerno 84131, Italy.
  • Verdú EF; Department of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton L8S4K1, ON, Canada.
  • Lebwohl B; The Celiac Disease Center, Columbia University, New York, NY 10032, United States.
  • Pinto-Sanchez MI; Department of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton L8S4K1, ON, Canada. pintosm@mcmaster.ca.
World J Gastroenterol ; 27(12): 1213-1225, 2021 Mar 28.
Article in English | MEDLINE | ID: covidwho-1172998
ABSTRACT

BACKGROUND:

We recently demonstrated that the odds of contracting coronavirus disease 2019 (COVID-19) in patients with celiac disease (CeD) is similar to that of the general population. However, how patients with CeD perceive their COVID-19 risk may differ from their actual risk.

AIM:

To investigate risk perceptions of contracting COVID-19 in patients with CeD and determine the factors that may influence their perception.

METHODS:

We distributed a survey throughout 10 countries between March and June 2020 and collected data on demographics, diet, COVID-19 testing, and risk perceptions of COVID-19 in patients with CeD. Participants were recruited through various celiac associations, clinic visits, and social media. Risk perception was assessed by asking individuals whether they believe patients with CeD are at an increased risk of contracting COVID-19 when compared to the general population. Logistic regression was used to determine the influencing factors associated with COVID-19 risk perception, such as age, sex, adherence to a gluten-free diet (GFD), and comorbidities such as cardiac conditions, respiratory conditions, and diabetes. Data was presented as adjusted odds ratios (aORs).

RESULTS:

A total of 10737 participants with CeD completed the survey. From them, 6019 (56.1%) patients with CeD perceived they were at a higher risk or were unsure if they were at a higher risk of contracting COVID-19 compared to the non-CeD population. A greater proportion of patients with CeD perceived an increased risk of contracting COVID-19 when compared to infections in general due to their CeD (56.1% vs 26.7%, P < 0.0001). Consequently, 34.8% reported taking extra COVID-19 precautions as a result of their CeD. Members of celiac associations were less likely to perceive an increased risk of COVID-19 when compared to non-members (49.5% vs 57.4%, P < 0.0001). Older age (aOR 0.99; 95%CI 0.99 to 0.99, P < 0.001), male sex (aOR 0.84; 95%CI 0.76 to 0.93, P = 0.001), and strict adherence to a GFD (aOR 0.89; 95%CI 0.82 to 0.96, P = 0.007) were associated with a lower perception of COVID-19 risk and the presence of comorbidities was associated with a higher perception of COVID-19 risk (aOR 1.38; 95%CI 1.22 to 1.54, P < 0.001).

CONCLUSION:

Overall, high levels of risk perceptions, such as those found in patients with CeD, may increase an individual's pandemic-related stress and contribute to negative mental health consequences. Therefore, it is encouraged that public health officials maintain consistent communication with the public and healthcare providers with the celiac community. Future studies specifically evaluating mental health in CeD could help determine the consequences of increased risk perceptions in this population.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Celiac Disease / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Aged / Humans / Male Language: English Journal: World J Gastroenterol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Wjg.v27.i12.1213

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Celiac Disease / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Aged / Humans / Male Language: English Journal: World J Gastroenterol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Wjg.v27.i12.1213